Literature DB >> 3118629

Autoclaved, formol-fixed scrapie mouse brain is suitable for histopathological examination, but may still be infective.

D M Taylor1, P A McBride.   

Abstract

Autoclaving Creutzfeldt-Jakob disease (CJD)-infected brain after fixation has been proposed previously as a means of making it safe for handling in the laboratory, while preserving its microscopic integrity. However, the practice which was recommended (126 degrees C for 30 min) would be unlikely to achieve complete decontamination. Autoclaving scrapie mouse brain (an analogue for CJD) to the higher, recommended standard of 134-138 degrees C for 18 min was found to lead to some tissue damage but not sufficient to prevent meaningful qualitative and quantitative study of the histopathological lesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118629     DOI: 10.1007/bf00692852

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  14 in total

1.  Decontamination of Creutzfeldt-Jakob disease agent.

Authors:  D M Taylor
Journal:  Ann Neurol       Date:  1986-12       Impact factor: 10.422

2.  Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease.

Authors:  P Duffy; J Wolf; G Collins; A G DeVoe; B Streeten; D Cowen
Journal:  N Engl J Med       Date:  1974-03-21       Impact factor: 91.245

3.  Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Committee on Health Care Issues, American Neurological Association.

Authors: 
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

4.  Decontamination of formaldehyde-fixed tissues of Creutzfeldt-Jakob disease.

Authors:  D M Taylor
Journal:  J Neuropathol Exp Neurol       Date:  1986-11       Impact factor: 3.685

5.  Decontamination of formaldehyde-fixed cerebral tissues of Creutzfeldt-Jakob disease by autoclaving, without the loss of microscopic visual quality.

Authors:  C L Masters; P Jacobsen; B A Kakulas
Journal:  J Neuropathol Exp Neurol       Date:  1985-05       Impact factor: 3.685

6.  Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery.

Authors:  C Bernoulli; J Siegfried; G Baumgartner; F Regli; T Rabinowicz; D C Gajdusek; C J Gibbs
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

7.  Chemical disinfection of Creutzfeldt-Jakob disease virus.

Authors:  P Brown; C J Gibbs; H L Amyx; D T Kingsbury; R G Rohwer; M P Sulima; D C Gajdusek
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

8.  Creutzfeldt-Jakob disease after administration of human growth hormone.

Authors:  J Powell-Jackson; R O Weller; P Kennedy; M A Preece; E M Whitcombe; J Newsom-Davis
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

9.  Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering.

Authors:  C L Masters; J O Harris; D C Gajdusek; C J Gibbs; C Bernoulli; D M Asher
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

10.  Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents.

Authors:  R H Kimberlin; C A Walker; G C Millson; D M Taylor; P A Robertson; A H Tomlinson; A G Dickinson
Journal:  J Neurol Sci       Date:  1983-06       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.